NCT05337735 2025-10-09
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
M.D. Anderson Cancer Center
Phase 2 Suspended
M.D. Anderson Cancer Center
Guangzhou Women and Children's Medical Center
Tri-Service General Hospital